beta
beta
EXPLORE
Search
Chat
Visualize
Browse
CONTRIBUTE
Hypothesis
Results
Question
Article
Posters
Peer Review
CV+
Overview
Peer Reviews
Authors
Citations
Related
/
Regulatory news: Avalglucosidase alfa‐ngpt (Nexviazyme) for late‐onset Pompe disease—FDA approval summary
Reviews
Join the dialogue
Submit a peer review to improve the scientific record
Start a Peer Review
Summary